title: Chronic treatment with a selective inhibitor of casein kinase I delta/epsilon yields cumulative phase delays in circadian rhythms.
abstract: BACKGROUND
  Casein kinase I epsilon/delta phosphorylates certain clock-related proteins as part of a complex arrangement of transcriptional/translational feedback loops that comprise the circadian oscillator in mammals. Pharmacologic inhibition leads to a delay of the oscillations with the magnitude of this effect dependent upon the timing of drug administration.
  
  
  OBJECTIVE
  Earlier studies by our lab described the actions of a selective CKI epsilon/delta inhibitor, PF-670462, on circadian behavior following acute dosing; the present work extended these studies to chronic once-daily treatment.
  
  
  METHODS
  Gross motor activity was used to estimate the circadian rhythms of rats maintained under a 12 L:12 D cycle. PF-670462, 10 or 30 mg/kg/day s.c., was administered once daily for 20 days either at ZT6 or ZT11 (i.e., 6 or 11 h after light onset).
  
  
  RESULTS
  Chronic administration of PF-670462, performed at a fixed time of day, produced delays in the activity onsets of rats that cumulated with the duration of dosing. Dosing at ZT11 yielded more robust delays than dosing at ZT6 in keeping with earlier phase-response analyses with this agent.
  
  
  CONCLUSIONS
  The magnitude of the shifts in activity onsets achieved with chronic dosing of PF-670462 appears to be a function of the dose and the previously established phase relationship. Its cumulative effect further suggests that the pharmacodynamic t (1/2) of the drug greatly exceeds its pharmacokinetic one. Most importantly, these changes in circadian behavior occurred in the presence of a fixed L:D cycle, confirming the drug to be a robust modulator of circadian phase in the presence of the natural zeitgeber.
authors.affiliation: Neuroscience Research Unit, Pfizer Global Research & Development, Groton, CT 06340, USA. JSPR@Lundbeck.com
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Sprouse
authors.forename: Linda
authors.initials: L
authors.lastname: Reynolds
authors.forename: Robin
authors.initials: R
authors.lastname: Kleiman
authors.forename: Barbara
authors.initials: B
authors.lastname: Tate
authors.forename: Terri A
authors.initials: TA
authors.lastname: Swanson
authors.forename: Gary E
authors.initials: GE
authors.lastname: Pickard
mesh_terms: D000818:Animals; D001683:Biological Clocks / Q000187:drug effects; D048149:Casein Kinase 1 epsilon / Q000037:antagonists & inhibitors*; D048148:Casein Kinase Idelta / Q000037:antagonists & inhibitors*; D002940:Circadian Rhythm / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D008297:Male; D009043:Motor Activity / Q000187:drug effects; D047428:Protein Kinase Inhibitors / Q000494:pharmacology*; D011743:Pyrimidines / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013997:Time Factors
chemical_list: D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; C522839:PF-670462; D048149:Casein Kinase 1 epsilon; D048148:Casein Kinase Idelta
references.citation: Nature. 2005 Mar 31;434(7033):640-4
references.pmid: 15800623
references.citation: Mol Cell Biol. 2002 Mar;22(6):1693-703
references.pmid: 11865049
references.citation: Sleep Med. 2007 Sep;8(6):623-36
references.pmid: 17383938
references.citation: J Pharmacol Exp Ther. 2007 Aug;322(2):730-8
references.pmid: 17502429
references.citation: Cell. 2001 Dec 28;107(7):855-67
references.pmid: 11779462
references.citation: Prog Brain Res. 2006;153:341-60
references.pmid: 16876585
references.citation: Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4453-8
references.pmid: 19255424
references.citation: Arch Gerontol Geriatr. 2000 Aug 1;31(1):65-76
references.pmid: 10989165
references.citation: Mol Cell Biol. 2005 Apr;25(7):2795-807
references.pmid: 15767683
references.citation: Nat Rev Genet. 2008 Oct;9(10):764-75
references.pmid: 18802415
references.citation: J Biol Rhythms. 2006 Dec;21(6):494-506
references.pmid: 17107939
references.citation: Cold Spring Harb Symp Quant Biol. 2007;72:477-82
references.pmid: 18419307
references.citation: Cold Spring Harb Symp Quant Biol. 2007;72:421-9
references.pmid: 18419300
references.citation: Am J Physiol. 1984 Mar;246(3 Pt 2):R299-304
references.pmid: 6703083
references.citation: Mol Cell Biol. 2009 Jul;29(14):3853-66
references.pmid: 19414593
references.citation: Diab Vasc Dis Res. 2008 Jun;5(2):89-95
references.pmid: 18537095
references.citation: Int Clin Psychopharmacol. 2006 Feb;21 Suppl 1:S11-5
references.pmid: 16436934
references.citation: Psychopharmacology (Berl). 2009 Jul;204(4):735-42
references.pmid: 19277609
references.citation: Ann Med. 2006;38(8):552-9
references.pmid: 17438670
references.citation: Am J Med Genet. 2002 May 8;114(4):391-406
references.pmid: 11992561
references.citation: Mol Cell Biol. 2000 Jul;20(13):4888-99
references.pmid: 10848614
references.citation: Eur Neuropsychopharmacol. 2006 Feb;16(2):93-100
references.pmid: 16249073
references.citation: J Neuroendocrinol. 2008 Jun;20(6):812-9
references.pmid: 18601704
references.citation: Endocrinology. 2007 Dec;148(12):5624-34
references.pmid: 17901233
references.citation: J Biol Rhythms. 2008 Feb;23(1):3-15
references.pmid: 18258753
references.citation: Int Clin Psychopharmacol. 2002 Sep;17(5):239-47
references.pmid: 12177586
references.citation: J Biol Chem. 2002 May 10;277(19):17248-54
references.pmid: 11875063
references.citation: Physiol Res. 2008;57 Suppl 3:S139-S148
references.pmid: 18481906
references.citation: Chronobiol Int. 2007;24(2):195-213
references.pmid: 17453843
references.citation: Biol Psychiatry. 1978 Jun;13(3):335-51
references.pmid: 667233
references.citation: J Pharmacol Exp Ther. 2009 Aug;330(2):430-9
references.pmid: 19458106
references.citation: Int Clin Psychopharmacol. 2007 Oct;22 Suppl 2:S1-8
references.pmid: 17917561
references.citation: Cold Spring Harb Symp Quant Biol. 2007;72:75-83
references.pmid: 18419264
references.citation: Curr Opin Microbiol. 2006 Dec;9(6):579-87
references.pmid: 17064954
references.citation: Cold Spring Harb Symp Quant Biol. 2007;72:167-76
references.pmid: 18419274
references.citation: Ann N Y Acad Sci. 2008;1129:358-70
references.pmid: 18591495
references.citation: J Neurosci. 1995 Mar;15(3 Pt 2):2109-22
references.pmid: 7534344
references.citation: J Neurosci Res. 2001 Jun 15;64(6):612-6
references.pmid: 11398185
references.citation: Sleep Med Rev. 2005 Feb;9(1):25-39
references.pmid: 15649736
references.citation: PLoS Genet. 2008 May 30;4(5):e1000040
references.pmid: 18516223
references.citation: Sleep Med Rev. 2009 Feb;13(1):47-60
references.pmid: 18845459
references.citation: J Clin Psychopharmacol. 2004 Aug;24(4):456-9
references.pmid: 15232344
references.citation: J Cell Sci. 2006 Dec 1;119(Pt 23):4793-5
references.pmid: 17130292
references.citation: J Genet. 2008 Dec;87(5):467-71
references.pmid: 19147935